“Cuba Transfers Pharmaceutical Know-How to Vietnam: Unlocking Boundless Opportunities”

Through this project, Vietnam aims to access and master advanced pharmaceutical technology, reducing dependence on imports, especially in the field of biologics and biotechnology, which is the global trend in the pharmaceutical industry.

This is also a path to enhance the research and development capabilities of Vietnam’s pharmaceutical industry. With the Genfarma project, Vietnamese people will have the opportunity to access high-quality medicines at reasonable costs, especially cancer treatment drugs.

Following the guidance of the leaders of both countries, the parties have actively discussed, worked, organized factory and laboratory visits, and exchanged expertise. With relentless efforts, the project has made significant progress in a short period.

In May 2025, a joint venture agreement was signed between BioCubaFarma SA (Cuba) and Vietnamese enterprises. Just three months later, the project took shape with modern infrastructure and a complete organization.

The Cuban partner is BioCubaFarma, the National Biopharmaceutical Group of Cuba. The group has 51 subsidiaries, including 9 joint ventures abroad, 6 of which have production facilities.

BioCubaFarma owns 21 scientific, technological, and innovation organizations with 396 R&D projects. They hold 2,300 patents and have registered 760 products in 53 countries. The company has exported more than 300 products to over 40 nations and transferred technology to Brazil, India, Venezuela, Algeria, China, Russia, Iran, and Vietnam, among others.

With the close and comprehensive cooperation between the pharmaceutical sectors of the two countries, the Genfarma project will enhance drug security and promote biotechnology in Vietnam while opening doors for Cuban biotechnology and pharmaceuticals to reach their full potential and advance into the global market.

During his visit to the Genfarma factory on August 31, Mr. Miguel Díaz-Canel, First Secretary of the Communist Party of Cuba and President of the Republic of Cuba, emphasized the pride Cuba has in its achievements in biologics and biotechnology.

“The technology transfer will bring mutual benefits and boost the production of important medicines for the people of both Vietnam and Cuba,” highlighted Mr. Miguel Díaz-Canel.

Ms. Dao Hong Lan, Minister of Health of Vietnam, also underlined the positive significance of the project. This is a concrete step to materialize the consensus reached between the leaders of the two countries during the visit to Cuba in September 2024 by Mr. To Lam, General Secretary of the Communist Party of Vietnam. The Ministry of Health has accompanied the enterprises from the initial stages of cooperation.

“The Ministry of Health is ready to further promote cooperation with the Ministry of Public Health of Cuba for the health of the people of both countries. The Genfarma project is a testament to the special friendship and strong bond between our two nations, and it is even more meaningful as it was initiated during the 65th anniversary of the establishment of diplomatic relations between Vietnam and Cuba,” emphasized Minister Dao Hong Lan.

At the reception for the high-ranking Cuban delegation and the delegation of Vietnamese ministries and sectors, the Genfarma leadership expressed their sincere gratitude to the First Secretary of the Communist Party of Cuba and President of the Republic of Cuba, and the leaders of the Party, State, and ministries, especially the Ministry of Public Security, Ministry of Health, Ministry of Construction, Ministry of Foreign Affairs, and the Embassy of Vietnam in Cuba, for their attention, support, and trust in entrusting this important task.

“Genfarma, together with its partner BioCubaFarma, is committed to dedicating all resources to accelerate progress and soon bring products to market, aiming at long-term sustainability,” the Genfarma leadership pledged.